Literature DB >> 11255282

p230 does not always predict a mild clinical course in myeloid malignancies: e19a2 bcr/abl fusion transcript with additional chromosome abnormalities in a patient with acute monoblastic leukemia (M5a).

P Bernasconi, S Calatroni, M Boni, P M Cavigliano, G Pagnucco, C Bernasconi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11255282

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  2 in total

Review 1.  Targeted therapy of chronic myeloid leukemia.

Authors:  Con Sullivan; Cong Peng; Yaoyu Chen; Dongguang Li; Shaoguang Li
Journal:  Biochem Pharmacol       Date:  2010-05-12       Impact factor: 5.858

2.  e19a2 BCR-ABL fusion transcript in typical chronic myeloid leukaemia: a report of two cases.

Authors:  B C Mondal; S Majumdar; U B Dasgupta; U Chaudhuri; P Chakrabarti; S Bhattacharyya
Journal:  J Clin Pathol       Date:  2006-10       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.